3Bao H, Liu ZH, Xie HL, et al. Successful treatment of class IV + V lu- pus nephritis with multitarget therapy [ J ]. J Am Soc Nephro1,2008, 17(10) :2001-2010.
9Takahiko K, Hayato N, Eiko N, et al. Successful treatment of class IV + V lupus nephritis with combination therapy of high-dose corticoste- roids, tacrolimus and intravenous cyclophosphamide [ J ]. Intern Med, 2013,52(10) :1125-1130.
10Ikeuchi H, Hiromura K, Takahashi S, et al. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis [ J ]. Mol Rheumatol,2014,24 (4) :618-625.
9Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins [J]. Cancer Lett, 2008, 269: 199-225.
10Nahta R, Yuan LXH, Du Y, et al. Lapatinib induces apoptosis in trastuzumab - resistant breast cancer cells: effects on insulinlike growth factor Ⅰ signaling [J]. Mol Cancer Ther, 2007, 6: 667-674.
5Dumont FJ. FK506, an immunosuppressant targeting calcineurin function [J]. Curt Med Chem, 2000, 7 (7): 731-748.
6Cho CS, Chang Z, Elkahwaji J, et al. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506) -mediated augmentation of linker for activation of T cell expression in T cell [ J]. Int lmmunol, 2003, 15 (11) : 1369-1378.
8Mok CC, Tong KH, To CH, et al. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study[J]. Kidney Int, 2005, 68 (2) : 813-817.
9Szeto CC, Kwan BC, Lai FM, et al. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis [J]. Rheumatology, 2008, 47 (11) : 1678-1681. B.
10ao H, Liu ZH, Xie HL, et al. Successful treatment of class V + IV lupus nephritis with multitarget therapy [J]. J Am Soc Nephrol, 2008, 19 (10) : 2001-2010.
